French Industry Head Lauds New Drug Pricing Deal
This article was originally published in The Pink Sheet Daily
Agreement includes reference price floor for products of higher therapeutic value; trade group says deal reflects "new pragmatism by regulators, with more predictability of pricing and more use of real-world data.
You may also be interested in...
New European legislation and rules on trademarks and trade secrets, the transatlantic transfer of data, and anticounterfeiting measures advanced during February, while streamlining generics approvals were featured during the EU-US TTIP negotiations; the UK referendum on whether to exit the EU set for mid-June.
France Seeks Stronger Cost-Effectiveness Tools To Lower Drug Prices, But Pan-European Bulk Buying May Come First
France’s drugs assessment agency wants simpler, stronger rules to evaluate the cost-effectiveness of new drugs. But changes to the country’s complex reimbursement system may be too slow to address immediate budget concerns, making pan-European bulk buying appear a more likely near-term solution.
The UK government says it is on track to vaccinate the 15 million most vulnerable people by mid-February, and that a “major study” is under way to assess the potential impact of the new UK variant on vaccine efficacy.